Editorial: Response and Resistance in Castration-Resistant Prostate Cancer

Renée de Leeuw, Qi Cao, Hung Ming Lam*

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

1 Scopus citations
Original languageEnglish (US)
Article number607298
JournalFrontiers in Oncology
Volume10
DOIs
StatePublished - Oct 23 2020

Funding

We are grateful to all authors that contributed to this e-book. Funding. RdL was supported by AUA Research Scholar Award and Prostate Cancer Foundation Young Investigator Award; QC by DoD (W81XWH1710357 and W81XWH1910563), ACS (RSG1519201), NIH/NCI (R01CA208257 and Prostate SPORE P50CA180995), and Northwestern Univ. Polsky Urologic Cancer Institute; H-ML by NIH Prostate Cancer SPORE (P50CA97186), DoD Prostate Cancer Biorepository Network, and Institute of Prostate Cancer Research. RdL was supported by AUA Research Scholar Award and Prostate Cancer Foundation Young Investigator Award; QC by DoD (W81XWH1710357 and W81XWH1910563), ACS (RSG1519201), NIH/NCI (R01CA208257 and Prostate SPORE P50CA180995), and Northwestern Univ. Polsky Urologic Cancer Institute; H-ML by NIH Prostate Cancer SPORE (P50CA97186), DoD Prostate Cancer Biorepository Network, and Institute of Prostate Cancer Research.

Keywords

  • androgen deprivation therapy (ADT)
  • castration-resistant prostate cancer
  • neuroendocrine prostate cancer
  • new therapy
  • treatment resistance

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this